Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.
about
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy, safety and pharmacok ...... multicentre prospective study.
@ast
Efficacy, safety and pharmacok ...... multicentre prospective study.
@en
type
label
Efficacy, safety and pharmacok ...... multicentre prospective study.
@ast
Efficacy, safety and pharmacok ...... multicentre prospective study.
@en
prefLabel
Efficacy, safety and pharmacok ...... multicentre prospective study.
@ast
Efficacy, safety and pharmacok ...... multicentre prospective study.
@en
P2093
P2860
P50
P356
P1476
Efficacy, safety and pharmacok ...... multicentre prospective study
@en
P2093
Agustin Muñoz-Sanz
Alberto Terrón
Antonio Vergara
Dolores Merino
Fernando Lozano
Josefa Ruiz
Luis González
Pompeyo Viciana
Rosa Ruiz-Valderas
P2860
P2888
P356
10.1186/1742-6405-7-5
P577
2010-03-17T00:00:00Z
P5875
P6179
1041936618